How you know , makes the difference!!
Meta Description: What is ICH Q3? Discover how these vital guidelines act as a global rulebook, ensuring the medicines you take are safe from harmful impurities. Learn about Q3A, Q3B, Q3C, and Q3D.
The world of pharmaceuticals is built on precision, reliability, and trust. At the heart of ensuring that medicines meet stringent quality standards lies ICH Q2, a globally recognized guideline that governs the validation of analytical procedures. For anyone involved in pharmaceutical development, quality control, or regulatory affairs, ICH Q2 is more than just a technical … Read more
Annex 11: Ensuring Compliance in Computerised Systems for GMP
Discover ICH Q14’s science-based approach to analytical procedure development, key contents, global implementation status, and comparison with ICH Q2.
QBD , Quality by Design, Pharma design, ICH Q9,, Q8, Q10
ICH Q13- guideline on continuous manufacturing in Pharma industry explained
The International Council for Harmonisation (ICH) Q12 guideline, titled “Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management,” provides a framework to streamline the management of post-approval changes for pharmaceutical products. Finalized in 2019, ICH Q12 aims to harmonize regulatory expectations, promote innovation, and ensure a consistent supply of high-quality medicines. By introducing tools like … Read more
Out-of-Specification (OOS) results are critical in the pharmaceutical industry as they directly relate to product quality, patient safety, and regulatory compliance. Regulatory agencies such as the USFDA (United States Food and Drug Administration) and MHRA (Medicines and Healthcare products Regulatory Agency) provide distinct guidelines to handle OOS results. While both aim to ensure compliance and … Read more
Out of Specification (OOS) and Out of Trend (OOT) guideline was published by MHRA (Medicines and Healthcare Products Regulatory Agency in October 2017 which is complementary to FDA guidance on investigating OOS Test results in Pharmaceutical Production October 2006. Investigations of “Out of Specification (OOS) / Out of Trend (OOT)/ Atypical results” have to be … Read more
